How to find a prognostic biomarker for progressive diabetic nephropathy.
Level V
Where this comes from
- Record sourced from PubMed, PMID 23728003.
- Also identified by DOI 10.1038/ki.2013.58 and PMC identifier 3994989.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
As a prognostic biomarker for progression of diabetic nephropathy, albuminuria fails in terms of sensitivity and specificity. Better urinary or plasma biomarkers are needed that can predict which diabetic patients are at highest risk for progression. Bhensdadia et al. report proteomic investigations that identified urinary haptoglobin as a potential prognostic biomarker for progressive diabetic nephropathy. Although as a single marker urinary haptoglobin adds little to albuminuria, together the two appear to provide better diagnostic accuracy than albuminuria alone.
Medical subject headings
- Diabetes Mellitus, Type 2
- Diabetic Nephropathies
- Haptoglobins
- Kidney